ȸ¿ø°¡ÀÔ | ¿¬¶ôó | »çÀÌÆ®¸Ê | English

      È¸»ç¼Ò°³ | ¸®Æ÷Æ® | Ä¿½ºÅÒ ¸®¼­Ä¡ | °í°´Áö¿ø


·Î±×ÀÎ

Ä«Å×°í¸®

À¯/¹«¼±Åë½Å

Àü±â/ÀüÀÚ

µðÁöÅбâ±â/¹Ìµð¾î/¹æ¼Û

Information Technology

¿¡³ÊÁö

»ý¸í°øÇÐ

È­ÇÐ/½Å¼ÒÀç

ÀÚµ¿Â÷

ȯ°æ

ÀϹݼҺñÀç

¸¶ÄÉÆÃ/±¤°í

±ÝÀ¶

°Ç¼³

±³Åë/¿î¼Û

¼ÒºñÀÚÁ¶»ç

¹æÀ§/Ç×°ø/¿ìÁÖ

½ÄÀ½·á

Áß°ø¾÷

±³À°

±â°è

¹«¿ª

½ºÆ÷Ã÷/·¹Àú

ÇØ¿î/Á¶¼±

ÆмÇ

Á¤ºÎ/Á¤Ã¥

°ø¿¹/±Í±Ý¼Ó

ÄÄÆÛ´Ï ÇÁ·ÎÆÄÀÏ

±âŸ»ê¾÷

 
ÇöÀçÀ§Ä¡ : HOME > ¸®Æ÷Æ® > »ý¸í°øÇÐ > Á¦¾à
Hepatobiliary Disease Global Clinical Trials Review, H1, 2015
¹ßÇà»ç GlobalData

¹ßÇàÀÏ 2015-04
ºÐ·® 51 pages
¼­ºñ½ºÇüÅ Report
ÆǸŰ¡°Ý

ÀμâÇϱâ

Table of Contents

Introduction
Hepatobiliary Disease
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Hepatobiliary Disease
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Clinical Trial Overview of Top Institutes / Government
Hiroshima University Hospital
Clinical Trial Overview of Hiroshima University Hospital
Hokkaido University Hospital
Clinical Trial Overview of Hokkaido University Hospital
Osaka University
Clinical Trial Overview of Osaka University
The University of Tokyo
Clinical Trial Overview of The University of Tokyo
Chiba University
Clinical Trial Overview of Chiba University
Guangdong Science and Technology Department
Clinical Trial Overview of Guangdong Science and Technology Department
Haydarpasa Numune State Hospital
Clinical Trial Overview of Haydarpasa Numune State Hospital
Hokkaido University School of Medicine
Clinical Trial Overview of Hokkaido University School of Medicine
Japanese Endoscopist & IVRists group for Biliary Tract Cancer
Clinical Trial Overview of Japanese Endoscopist & IVRists group for Biliary Tract Cancer
Kyoto Prefectural University of Medicine
Clinical Trial Overview of Kyoto Prefectural University of Medicine
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source


List of Tables

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region, 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries, 2015*
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase, 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
Hepatobiliary Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015*
Hepatobiliary Disease Therapeutics, Global, Terminated Clinical Trials, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University Hospital, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Science and Technology Department, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Haydarpasa Numune State Hospital, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Endoscopist & IVRists group for Biliary Tract Cancer, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015*


List of Figures

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region (%), 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
GlobalData Methodology


ȸ»ç¼Ò°³ | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | ¹è¼Û/°áÁ¦¾È³» | ÀÌ¿ë¾È³»

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 210-1 »ï¿øºôµù | ȸ»ç¸í : (ÁÖ)¿¤¾Ø¿¡Ä¡
´ëÇ¥ÀüÈ­ : 02-554-0001 / Æѽº : 02-3444-5501 / À̸ÞÀÏ : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.